National Health Investors (NHI) Liabilities and Shareholders Equity (2016 - 2026)
National Health Investors filings provide 18 years of Liabilities and Shareholders Equity readings, the most recent being $2.9 billion for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 3.84% to $2.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $11.1 billion, a 7.15% increase, with the full-year FY2025 number at $2.8 billion, up 6.98% from a year prior.
- Liabilities and Shareholders Equity hit $2.9 billion in Q1 2026 for National Health Investors, up from $2.8 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.9 billion in Q1 2026 to a low of $2.5 billion in Q3 2024.
- Median Liabilities and Shareholders Equity over the past 5 years was $2.5 billion (2023), compared with a mean of $2.6 billion.
- Biggest five-year swings in Liabilities and Shareholders Equity: decreased 15.93% in 2022 and later increased 12.3% in 2025.
- National Health Investors' Liabilities and Shareholders Equity stood at $2.5 billion in 2022, then dropped by 0.76% to $2.5 billion in 2023, then grew by 5.06% to $2.6 billion in 2024, then increased by 6.98% to $2.8 billion in 2025, then increased by 3.32% to $2.9 billion in 2026.
- The last three reported values for Liabilities and Shareholders Equity were $2.9 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.7 billion (Q3 2025) per Business Quant data.